TrialBlood2019

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.

Laura Rosiñol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.